Your browser doesn't support javascript.
loading
Exploring SureChEMBL from a drug discovery perspective.
Gadiya, Yojana; Shetty, Simran; Hofmann-Apitius, Martin; Gribbon, Philip; Zaliani, Andrea.
Afiliação
  • Gadiya Y; Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Schnackenburgallee 114, 22525, Hamburg, Germany. Yojana.Gadiya@itmp.fraunhofer.de.
  • Shetty S; Fraunhofer Cluster of Excellence for Immune-Mediated Diseases (CIMD), Theodor Stern Kai 7, 60590, Frankfurt, Germany. Yojana.Gadiya@itmp.fraunhofer.de.
  • Hofmann-Apitius M; Bonn-Aachen International Center for Information Technology (B-IT), University of Bonn, 53113, Bonn, Germany. Yojana.Gadiya@itmp.fraunhofer.de.
  • Gribbon P; Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Schnackenburgallee 114, 22525, Hamburg, Germany.
  • Zaliani A; Fraunhofer Cluster of Excellence for Immune-Mediated Diseases (CIMD), Theodor Stern Kai 7, 60590, Frankfurt, Germany.
Sci Data ; 11(1): 507, 2024 May 16.
Article em En | MEDLINE | ID: mdl-38755219
ABSTRACT
In the pharmaceutical industry, the patent protection of drugs and medicines is accorded importance because of the high costs involved in the development of novel drugs. Over the years, researchers have analyzed patent documents to identify freedom-to-operate spaces for novel drug candidates. To assist this, several well-established public patent document data repositories have enabled automated methodologies for extracting information on therapeutic agents. In this study, we delve into one such publicly available patent database, SureChEMBL, which catalogues patent documents related to life sciences. Our exploration begins by identifying patent compounds across public chemical data resources, followed by pinpointing sections in patent documents where the chemical annotations were found. Next, we exhibit the potential of compounds to serve as drug candidates by evaluating their conformity to drug-likeness criteria. Lastly, we examine the drug development stage reported for these compounds to understand their clinical success. In summary, our investigation aims at providing a comprehensive overview of the patent compounds catalogued in SureChEMBL, assessing their relevance to pharmaceutical drug discovery.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Patentes como Assunto / Bases de Dados Factuais / Descoberta de Drogas Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Patentes como Assunto / Bases de Dados Factuais / Descoberta de Drogas Idioma: En Ano de publicação: 2024 Tipo de documento: Article